Completed Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex NCT02634931 Conditions Angiofibroma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more Locations Graduate School of Medicine, Osaka University — Suita, Osaka, Japan View Trial Details
Completed Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) NCT02635789 Conditions Angiofibroma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more Locations Graduate School of Medicine, Osaka University — Suita, Osaka, Japan View Trial Details
